103 related articles for article (PubMed ID: 26800447)
21. Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780.
Wu Y; Guo SW
Gynecol Obstet Invest; 2006; 62(4):193-205. PubMed ID: 16778450
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of estrogen and estrogen receptor antagonist, ICI 182 780, on the expression of calbindin-D9k in rat pituitary prolactinoma GH₃ cells.
Wang W; Knosp E; Tai G; Zhao Y; Liang Q; Guo Y
Int J Clin Exp Pathol; 2014; 7(12):8498-505. PubMed ID: 25674214
[TBL] [Abstract][Full Text] [Related]
23. Effects of the Catechol and Methoxy Metabolites of 17β-Estradiol on Nitric Oxide Production by Ovine Uterine Artery Endothelial Cells.
Landeros RV; Pastore MB; Magness RR
Reprod Sci; 2019 Apr; 26(4):459-468. PubMed ID: 29929429
[TBL] [Abstract][Full Text] [Related]
24. Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells.
Seeger H; Wallwiener D; Kraemer E; Mueck AO
Eur J Gynaecol Oncol; 2005; 26(4):383-5. PubMed ID: 16122183
[TBL] [Abstract][Full Text] [Related]
25. Expression and mitogenic effect of fibroblast growth factor-9 in human endometriotic implant is regulated by aberrant production of estrogen.
Wing LY; Chuang PC; Wu MH; Chen HM; Tsai SJ
J Clin Endocrinol Metab; 2003 Nov; 88(11):5547-54. PubMed ID: 14602803
[TBL] [Abstract][Full Text] [Related]
26. Effects of estrogen metabolite 2-methoxyestradiol on tumor suppressor protein p53 and proliferation of breast cancer cells.
Siebert AE; Sanchez AL; Dinda S; Moudgil VK
Syst Biol Reprod Med; 2011 Dec; 57(6):279-87. PubMed ID: 22077725
[TBL] [Abstract][Full Text] [Related]
27. Effects of estradiol metabolites on cAMP production and degradation.
Tofovic PS; Rosado BM; Dubey KR; Mi Z; Jackson EK
Prilozi; 2009 Jul; 30(1):5-24. PubMed ID: 19736528
[TBL] [Abstract][Full Text] [Related]
28. Radioimmunoassay and metabolism of the catechol estrogen 2-hydroxyestradiol.
Kono S; Merriam GR; Brandon DD; Loriaux DL; Lipsett MB
J Clin Endocrinol Metab; 1982 Jan; 54(1):150-4. PubMed ID: 7054211
[TBL] [Abstract][Full Text] [Related]
29. The effects of fulvestrant, an estrogen receptor antagonist, on the proliferation, differentiation and mineralization of osteoprecursor cells.
Park JB
Mol Med Rep; 2013 Feb; 7(2):555-8. PubMed ID: 23179494
[TBL] [Abstract][Full Text] [Related]
30. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
LaVallee TM; Zhan XH; Herbstritt CJ; Kough EC; Green SJ; Pribluda VS
Cancer Res; 2002 Jul; 62(13):3691-7. PubMed ID: 12097276
[TBL] [Abstract][Full Text] [Related]
31. Endometriotic implants regress in rat models treated with puerarin by decreasing estradiol level.
Chen Y; Chen C; Shi S; Han J; Wang J; Hu J; Liu Y; Cai Z; Yu C
Reprod Sci; 2011 Sep; 18(9):886-91. PubMed ID: 21673282
[TBL] [Abstract][Full Text] [Related]
32. Cytochromes 1A1/1B1- and catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast.
Dubey RK; Jackson EK; Gillespie DG; Rosselli M; Barchiesi F; Krust A; Keller H; Zacharia LC; Imthurn B
J Clin Endocrinol Metab; 2005 Jan; 90(1):247-55. PubMed ID: 15507517
[TBL] [Abstract][Full Text] [Related]
33. Effect of estradiol and bisphenol A on human hepatoblastoma cell viability and telomerase activity.
Xu BL; Zhao QZ; Gao XY; Hou GJ
Braz J Med Biol Res; 2015 Nov; 48(11):1004-9. PubMed ID: 26397976
[TBL] [Abstract][Full Text] [Related]
34. Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth.
Dubey RK; Gillespie DG; Zacharia LC; Rosselli M; Imthurn B; Jackson EK
Hypertension; 2002 Feb; 39(2 Pt 2):412-7. PubMed ID: 11882582
[TBL] [Abstract][Full Text] [Related]
35. Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial-to-mesenchymal transition in the peritoneum.
Ono YJ; Hayashi M; Tanabe A; Hayashi A; Kanemura M; Terai Y; Ohmichi M
Am J Physiol Endocrinol Metab; 2015 Jun; 308(11):E950-9. PubMed ID: 25852006
[TBL] [Abstract][Full Text] [Related]
36. Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression.
Huang Y; Jiang D; Sui M; Wang X; Fan W
Oncol Rep; 2017 Feb; 37(2):705-712. PubMed ID: 28000875
[TBL] [Abstract][Full Text] [Related]
37. Estradiol promotes pituitary cell proliferation and gonadotroph differentiation at different doses and with different mechanisms in chick embryo.
Wu YJ; Chen DW; Liu JL; Zhang JH; Luo HS; Cui S
Steroids; 2009; 74(4-5):441-8. PubMed ID: 19150621
[TBL] [Abstract][Full Text] [Related]
38. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
39. Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia.
Capellino S; Montagna P; Villaggio B; Soldano S; Straub RH; Cutolo M
Clin Exp Rheumatol; 2008; 26(5):903-9. PubMed ID: 19032826
[TBL] [Abstract][Full Text] [Related]
40. Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis.
Leyh B; Dittmer A; Lange T; Martens JW; Dittmer J
Oncotarget; 2015 Nov; 6(36):39307-28. PubMed ID: 26515727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
